THE NEED IS REAL
To dramatically improve outcomes we need to improve management.
To improve management, we first need to improve measurement.
That’s what Octave is here to do.
The challenges for multiple sclerosis are significant, the issues are overwhelming, and the needs are mostly unmet. That’s why Octave is creating a comprehensive, measurement driven Care Management Platform for MS.
MS is a chronic, debilitating, high cost disease with variable outcomes.
THE BIG PICTURE ABOUT MULTIPLE SCLEROSIS
Late 20’s average onset, affects 3:1 women to men
Long term costs include medical, drug, ancillaries and disability
Symptom burden and co-morbidities impact employment
Varied mechanisms, efficacy, side effects and tolerability
$60-80,000 per year, over $14B spend, with unguided use
MS disease course is driven by inflammation, demyelination and axonal damage. Yet, the tools to assess these are subjective, qualitative and inadequate.
THIS PROVIDES FOR BETTER MANAGEMENT
Stakeholders need better information that is highly actionable.
Octave’s three layer model of biological, clinical and economic data combined with sophisticated analytics, contextualization, machine learning and AI provide new insights for Physicians, Patients, Payers, and Pharma.